These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 8091321

  • 1. Systemic effects of salbutamol and salmeterol in patients with asthma.
    Bennett JA, Smyth ET, Pavord ID, Wilding PJ, Tattersfield AE.
    Thorax; 1994 Aug; 49(8):771-4. PubMed ID: 8091321
    [Abstract] [Full Text] [Related]

  • 2. Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma.
    Smyth ET, Pavord ID, Wong CS, Wisniewski AF, Williams J, Tattersfield AE.
    BMJ; 1993 Feb 27; 306(6877):543-5. PubMed ID: 8096416
    [Abstract] [Full Text] [Related]

  • 3. Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma.
    Higham MA, Sharara AM, Wilson P, Jenkins RJ, Glendenning GA, Ind PW.
    Thorax; 1997 Nov 27; 52(11):975-80. PubMed ID: 9487346
    [Abstract] [Full Text] [Related]

  • 4. Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects.
    Bennett JA, Tattersfield AE.
    Thorax; 1997 May 27; 52(5):458-64. PubMed ID: 9176539
    [Abstract] [Full Text] [Related]

  • 5. Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
    Ullman A, Svedmyr N.
    Thorax; 1988 Sep 27; 43(9):674-8. PubMed ID: 2904183
    [Abstract] [Full Text] [Related]

  • 6. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ, Winter TH, Aalbers R.
    Thorax; 2001 Jul 27; 56(7):529-35. PubMed ID: 11413351
    [Abstract] [Full Text] [Related]

  • 7. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma.
    Simons FE, Soni NR, Watson WT, Becker AB.
    J Allergy Clin Immunol; 1992 Nov 27; 90(5):840-6. PubMed ID: 1358932
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M, Centanni S, Boveri B, Di Marco F, Santus P, Matera MG, Allegra L.
    Respiration; 2001 Nov 27; 68(5):452-9. PubMed ID: 11694805
    [Abstract] [Full Text] [Related]

  • 9. Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study.
    Wilding P, Clark M, Thompson Coon J, Lewis S, Rushton L, Bennett J, Oborne J, Cooper S, Tattersfield AE.
    BMJ; 1997 May 17; 314(7092):1441-6. PubMed ID: 9167559
    [Abstract] [Full Text] [Related]

  • 10. The first 20 minutes after a single dose of inhaled salmeterol in asthmatic children.
    Barbato A, Cracco A, Tormena F, Novello A.
    Allergy; 1995 Jun 17; 50(6):506-10. PubMed ID: 7573844
    [Abstract] [Full Text] [Related]

  • 11. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients.
    Grove A, Lipworth BJ.
    Lancet; 1995 Jul 22; 346(8969):201-6. PubMed ID: 7616798
    [Abstract] [Full Text] [Related]

  • 12. Bronchodilator response to salbutamol after chronic dosing with salmeterol or placebo.
    Langley SJ, Masterson CM, Batty EP, Woodcock A.
    Eur Respir J; 1998 May 22; 11(5):1081-5. PubMed ID: 9648959
    [Abstract] [Full Text] [Related]

  • 13. Twelve months, treatment with inhaled salmeterol in asthmatic patients. Effects on beta 2-receptor function and inflammatory cells.
    Lötvall J, Lunde H, Ullman A, Törnqvist H, Svedmyr N.
    Allergy; 1992 Oct 22; 47(5):477-83. PubMed ID: 1362481
    [Abstract] [Full Text] [Related]

  • 14. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.
    Lundback B, Rawlinson DW, Palmer JB.
    Thorax; 1993 Feb 22; 48(2):148-53. PubMed ID: 8493629
    [Abstract] [Full Text] [Related]

  • 15. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI.
    JAMA; 1994 May 11; 271(18):1412-6. PubMed ID: 7909853
    [Abstract] [Full Text] [Related]

  • 16. [Efficacy of and tolerance to salmeterol compared to salbutamol in patients with bronchial asthma].
    De Oliveira MA, Jardim JR, Faresin SM, Lucas SR, Nery LE.
    Rev Assoc Med Bras (1992); 1998 May 11; 44(3):169-75. PubMed ID: 9755543
    [Abstract] [Full Text] [Related]

  • 17. Rapid onset of tolerance to the bronchoprotective effect of salmeterol.
    Bhagat R, Kalra S, Swystun VA, Cockcroft DW.
    Chest; 1995 Nov 11; 108(5):1235-9. PubMed ID: 7587422
    [Abstract] [Full Text] [Related]

  • 18. Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics.
    Wong AG, O'Shaughnessy AD, Walker CM, Sears MR.
    Eur Respir J; 1997 Feb 11; 10(2):330-6. PubMed ID: 9042628
    [Abstract] [Full Text] [Related]

  • 19. Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects.
    Guhan AR, Cooper S, Oborne J, Lewis S, Bennett J, Tattersfield AE.
    Thorax; 2000 Aug 11; 55(8):650-6. PubMed ID: 10899240
    [Abstract] [Full Text] [Related]

  • 20. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
    Britton MG, Earnshaw JS, Palmer JB.
    Eur Respir J; 1992 Oct 11; 5(9):1062-7. PubMed ID: 1426215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.